English

SCIELE PHARMA, INC.

EDGAR

Quarterly report (10-Q) · filed 2008-07-31

40 filing records in this dataset, filed from 2000-08-10 to 2008-07-31. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

103 million USD

2008-06-30 · USD

Exact inputs and evidence

Revenue: 103238000 USD Source

Operating margin

13.03%

2008-06-30 · %

Exact inputs and evidence

Operating Income: 13452000 USD Source
Revenue: 103238000 USD Source

Operating cash flow

16.5 million USD

2008-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: 39138000 USD Source
Operating Cash Flow: 22620000 USD Source

Cash and cash equivalents: 88.7 million USD 2008-06-30 Source
Exact value

88675000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

408 million USD

2007-07-01 – 2008-06-30

Exact inputs and evidence

Revenue: 99372000 USD · 2007-07-01 – 2007-09-30 Source
Revenue: 382255000 USD · 2007-01-01 – 2007-12-31 Source
Revenue: 277291000 USD · 2007-01-01 – 2007-09-30 Source
Revenue: 100438000 USD · 2008-01-01 – 2008-03-31 Source
Revenue: 103238000 USD · 2008-04-01 – 2008-06-30 Source

Net income

45.3 million USD

2007-07-01 – 2008-06-30

Exact inputs and evidence

Net income: 10656000 USD · 2007-07-01 – 2007-09-30 Source
Net income: 45407000 USD · 2007-01-01 – 2007-12-31 Source
Net income: 34292000 USD · 2007-01-01 – 2007-09-30 Source
Net income: 11546000 USD · 2008-01-01 – 2008-03-31 Source
Net income: 12005000 USD · 2008-04-01 – 2008-06-30 Source

Operating cash flow

65.9 million USD

2007-07-01 – 2008-06-30

Exact inputs and evidence

Operating cash flow: 42268000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: 36897000 USD · 2007-01-01 – 2007-06-30 Source
Operating cash flow: 63682000 USD · 2007-01-01 – 2007-12-31 Source
Operating cash flow: 42268000 USD · 2007-01-01 – 2007-09-30 Source
Operating cash flow: 22620000 USD · 2008-01-01 – 2008-03-31 Source
Operating cash flow: 39138000 USD · 2008-01-01 – 2008-06-30 Source
Operating cash flow: 22620000 USD · 2008-01-01 – 2008-03-31 Source

Capital expenditure

27.6 million USD

2007-04-01 – 2008-03-31

Exact inputs and evidence

Capital expenditure: 7767000 USD · 2007-01-01 – 2007-06-30 Source
Capital expenditure: 905000 USD · 2007-01-01 – 2007-03-31 Source
Capital expenditure: 12542000 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 7767000 USD · 2007-01-01 – 2007-06-30 Source
Capital expenditure: 22958000 USD · 2007-01-01 – 2007-12-31 Source
Capital expenditure: 12542000 USD · 2007-01-01 – 2007-09-30 Source
Capital expenditure: 5508000 USD · 2008-01-01 – 2008-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2008-07-31.

Financial data available through: 2007-12-31.

Coverage by financial measure

Revenue: 10 of 11 periods available· newest 2007-12-31
Operating income: 10 of 11 periods available· newest 2007-12-31
Net income: 10 of 11 periods available· newest 2007-12-31
Operating cash flow: 10 of 11 periods available· newest 2007-12-31
Capital expenditure: 10 of 11 periods available· newest 2007-12-31
Total assets: 9 of 11 periods available· newest 2007-12-31
Total liabilities: 9 of 11 periods available· newest 2007-12-31
Current assets: 9 of 11 periods available· newest 2007-12-31
Current liabilities: 9 of 11 periods available· newest 2007-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2007-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+30.4%

Prior period

USD 293.18 million

2006-01-01 – 2006-12-31
Current period

USD 382.26 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

382255000 − 293181000 = 89074000 USD

293181000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
382255000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · SCIELE PHARMA, INC. · 2007-12-31 SCIELE PHARMA, INC. (edgar:1106773) Year-over-year change in Revenue: 89074000 USD Concept: fundies:Revenue Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 382255000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#6098 Input fundies:Revenue: 293181000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#6098
The citation records this snapshot. The page link may show a newer release later.
Net income
+0.4%

Prior period

USD 45.24 million

2006-01-01 – 2006-12-31
Current period

USD 45.41 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

45407000 − 45244000 = 163000 USD

45244000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
45407000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · SCIELE PHARMA, INC. · 2007-12-31 SCIELE PHARMA, INC. (edgar:1106773) Year-over-year change in Net income: 163000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 45407000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#7959 Input fundies:NetIncome: 45244000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#7959
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
-30.6%

Prior period

USD 91.81 million

2006-01-01 – 2006-12-31
Current period

USD 63.68 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

63682000 − 91812000 = -28130000 USD

91812000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
63682000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · SCIELE PHARMA, INC. · 2007-12-31 SCIELE PHARMA, INC. (edgar:1106773) Year-over-year change in Operating cash flow: -28130000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 63682000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8243 Input fundies:OperatingCashFlow: 91812000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8243
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+421.8%

Prior period

USD 4.4 million

2006-01-01 – 2006-12-31
Current period

USD 22.96 million

2007-01-01 – 2007-12-31

Exact inputs and evidence

22958000 − 4400000 = 18558000 USD

4400000 USD · 2006-01-01 – 2006-12-31
Inspect prior input Prior source
22958000 USD · 2007-01-01 – 2007-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · SCIELE PHARMA, INC. · 2007-12-31 SCIELE PHARMA, INC. (edgar:1106773) Year-over-year change in Capital expenditure: 18558000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 22958000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8297 Input fundies:CapitalExpenditure: 4400000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8297
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2007 2007-01-01 – 2007-12-31

Revenue USD 382.26 million 100% of revenue
Cost of revenue USD 52.76 million 14% of revenue
Operating expenses USD 223.48 million 58% of revenue
Other operating costs Derived USD 28.43 million 7.4% of revenue
Operating income USD 77.59 million 20% of revenue
Tax, interest and other Derived USD 32.18 million 8.4% of revenue
Net income USD 45.41 million 12% of revenue

Cash

Operating cash flow USD 63.68 million 17% of revenue
Capital expenditure USD 22.96 million 6% of revenue
Free cash flow Derived USD 40.72 million 11% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1998 97%
1999 91%
2000 89%
2001 15%77%
2002 88%
2003 Operating loss: operating costs were 103% of revenue.
2004 17%75%
2005 18%9.1%73%
2006 15%78%
2007 12%80%

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1998 1998-01-01 – 1998-12-31	9252058	8982637 Derived	269421	133867 Derived	135554	-389006 Derived	Source 1998-01-01 – 1998-12-31: 9252058 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: 269421 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: 135554 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -180542 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 208464 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	18625000	16970000 Derived	1655000	885000 Derived	770000	833000 Derived	Source 1999-01-01 – 1999-12-31: 18625000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: 1655000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: 770000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: 1019000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 186000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	36650000	32528000 Derived	4122000	1615000 Derived	2507000	2728000 Derived	Source 2000-01-01 – 2000-12-31: 36650000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: 4122000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: 2507000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: 3275000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 547000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	69290000	53586000 Derived	15704000	4981000 Derived	10723000	23856000 Derived	Source 2001-01-01 – 2001-12-31: 69290000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: 15704000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: 10723000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 24047000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 191000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	115178000	101377000 Derived	13801000	7635000 Derived	6166000	25973000 Derived	Source 2002-01-01 – 2002-12-31: 115178000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: 13801000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: 6166000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 27313000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 1340000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	95305000	98282000 Derived	-2977000	-1239000 Derived	-1738000	-3378000 Derived	Source 2003-01-01 – 2003-12-31: 95305000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: -2977000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -1738000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: -1587000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 1791000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	151967000	114308000 Derived	37659000	11105000 Derived	26554000	46003000 Derived	Source 2004-01-01 – 2004-12-31: 151967000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: 37659000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: 26554000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 49487000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 3484000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	216358000	157458000 Derived	58900000	19691000 Derived	39209000	18099000 Derived	Source 2005-01-01 – 2005-12-31: 216358000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: 58900000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 39209000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 20297000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 2198000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	293181000	228470000 Derived	64711000	19467000 Derived	45244000	87412000 Derived	Source 2006-01-01 – 2006-12-31: 293181000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: 64711000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: 45244000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 91812000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 4400000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	382255000	304667000 Derived	77588000	32181000 Derived	45407000	40724000 Derived	Source 2007-01-01 – 2007-12-31: 382255000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 77588000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 45407000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 63682000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 22958000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 382.3M 2007

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Revenue	9252058	Revenue: 9252058 Open source
19991999-12-31	Revenue	18625000	Revenue: 18625000 Open source
20002000-12-31	Revenue	36650000	Revenue: 36650000 Open source
20012001-12-31	Revenue	69290000	Revenue: 69290000 Open source
20022002-12-31	Revenue	115178000	Revenue: 115178000 Open source
20032003-12-31	Revenue	95305000	Revenue: 95305000 Open source
20042004-12-31	Revenue	151967000	Revenue: 151967000 Open source
20052005-12-31	Revenue	216358000	Revenue: 216358000 Open source
20062006-12-31	Revenue	293181000	Revenue: 293181000 Open source
20072007-12-31	Revenue	382255000	Revenue: 382255000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

30.4% 2007

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Year over year	No prior comparable period	Revenue: 9252058 Open source
19991999-12-31	Year over year	101.3%	Revenue: 18625000 Open source Revenue: 9252058 Open source
20002000-12-31	Year over year	96.8%	Revenue: 36650000 Open source Revenue: 18625000 Open source
20012001-12-31	Year over year	89.1%	Revenue: 69290000 Open source Revenue: 36650000 Open source
20022002-12-31	Year over year	66.2%	Revenue: 115178000 Open source Revenue: 69290000 Open source
20032003-12-31	Year over year	-17.3%	Revenue: 95305000 Open source Revenue: 115178000 Open source
20042004-12-31	Year over year	59.5%	Revenue: 151967000 Open source Revenue: 95305000 Open source
20052005-12-31	Year over year	42.4%	Revenue: 216358000 Open source Revenue: 151967000 Open source
20062006-12-31	Year over year	35.5%	Revenue: 293181000 Open source Revenue: 216358000 Open source
20072007-12-31	Year over year	30.4%	Revenue: 382255000 Open source Revenue: 293181000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 20.3% 2007

Net margin 11.9% 2007

Free cash flow margin 10.7% 2007

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Operating margin	2.9%	Operating Income: 269421 Open source Revenue: 9252058 Open source
19991999-12-31	Operating margin	8.9%	Operating Income: 1655000 Open source Revenue: 18625000 Open source
20002000-12-31	Operating margin	11.2%	Operating Income: 4122000 Open source Revenue: 36650000 Open source
20012001-12-31	Operating margin	22.7%	Operating Income: 15704000 Open source Revenue: 69290000 Open source
20022002-12-31	Operating margin	12%	Operating Income: 13801000 Open source Revenue: 115178000 Open source
20032003-12-31	Operating margin	-3.1%	Operating Income: -2977000 Open source Revenue: 95305000 Open source
20042004-12-31	Operating margin	24.8%	Operating Income: 37659000 Open source Revenue: 151967000 Open source
20052005-12-31	Operating margin	27.2%	Operating Income: 58900000 Open source Revenue: 216358000 Open source
20062006-12-31	Operating margin	22.1%	Operating Income: 64711000 Open source Revenue: 293181000 Open source
20072007-12-31	Operating margin	20.3%	Operating Income: 77588000 Open source Revenue: 382255000 Open source
19981998-12-31	Net margin	1.5%	Net Income: 135554 Open source Revenue: 9252058 Open source
19991999-12-31	Net margin	4.1%	Net Income: 770000 Open source Revenue: 18625000 Open source
20002000-12-31	Net margin	6.8%	Net Income: 2507000 Open source Revenue: 36650000 Open source
20012001-12-31	Net margin	15.5%	Net Income: 10723000 Open source Revenue: 69290000 Open source
20022002-12-31	Net margin	5.4%	Net Income: 6166000 Open source Revenue: 115178000 Open source
20032003-12-31	Net margin	-1.8%	Net Income: -1738000 Open source Revenue: 95305000 Open source
20042004-12-31	Net margin	17.5%	Net Income: 26554000 Open source Revenue: 151967000 Open source
20052005-12-31	Net margin	18.1%	Net Income: 39209000 Open source Revenue: 216358000 Open source
20062006-12-31	Net margin	15.4%	Net Income: 45244000 Open source Revenue: 293181000 Open source
20072007-12-31	Net margin	11.9%	Net Income: 45407000 Open source Revenue: 382255000 Open source
19981998-12-31	Free cash flow margin	-4.2%	Revenue: 9252058 Open source Operating Cash Flow: -180542 Open source Capital Expenditure: 208464 Open source
19991999-12-31	Free cash flow margin	4.5%	Revenue: 18625000 Open source Operating Cash Flow: 1019000 Open source Capital Expenditure: 186000 Open source
20002000-12-31	Free cash flow margin	7.4%	Revenue: 36650000 Open source Operating Cash Flow: 3275000 Open source Capital Expenditure: 547000 Open source
20012001-12-31	Free cash flow margin	34.4%	Revenue: 69290000 Open source Operating Cash Flow: 24047000 Open source Capital Expenditure: 191000 Open source
20022002-12-31	Free cash flow margin	22.6%	Revenue: 115178000 Open source Operating Cash Flow: 27313000 Open source Capital Expenditure: 1340000 Open source
20032003-12-31	Free cash flow margin	-3.5%	Revenue: 95305000 Open source Operating Cash Flow: -1587000 Open source Capital Expenditure: 1791000 Open source
20042004-12-31	Free cash flow margin	30.3%	Revenue: 151967000 Open source Operating Cash Flow: 49487000 Open source Capital Expenditure: 3484000 Open source
20052005-12-31	Free cash flow margin	8.4%	Revenue: 216358000 Open source Operating Cash Flow: 20297000 Open source Capital Expenditure: 2198000 Open source
20062006-12-31	Free cash flow margin	29.8%	Revenue: 293181000 Open source Operating Cash Flow: 91812000 Open source Capital Expenditure: 4400000 Open source
20072007-12-31	Free cash flow margin	10.7%	Revenue: 382255000 Open source Operating Cash Flow: 63682000 Open source Capital Expenditure: 22958000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 63.7M 2007

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Operating cash flow	-180542	Operating Cash Flow: -180542 Open source
19991999-12-31	Operating cash flow	1019000	Operating Cash Flow: 1019000 Open source
20002000-12-31	Operating cash flow	3275000	Operating Cash Flow: 3275000 Open source
20012001-12-31	Operating cash flow	24047000	Operating Cash Flow: 24047000 Open source
20022002-12-31	Operating cash flow	27313000	Operating Cash Flow: 27313000 Open source
20032003-12-31	Operating cash flow	-1587000	Operating Cash Flow: -1587000 Open source
20042004-12-31	Operating cash flow	49487000	Operating Cash Flow: 49487000 Open source
20052005-12-31	Operating cash flow	20297000	Operating Cash Flow: 20297000 Open source
20062006-12-31	Operating cash flow	91812000	Operating Cash Flow: 91812000 Open source
20072007-12-31	Operating cash flow	63682000	Operating Cash Flow: 63682000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 40.7M 2007

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Free cash flow	-389006	Operating Cash Flow: -180542 Open source Capital Expenditure: 208464 Open source
19991999-12-31	Free cash flow	833000	Operating Cash Flow: 1019000 Open source Capital Expenditure: 186000 Open source
20002000-12-31	Free cash flow	2728000	Operating Cash Flow: 3275000 Open source Capital Expenditure: 547000 Open source
20012001-12-31	Free cash flow	23856000	Operating Cash Flow: 24047000 Open source Capital Expenditure: 191000 Open source
20022002-12-31	Free cash flow	25973000	Operating Cash Flow: 27313000 Open source Capital Expenditure: 1340000 Open source
20032003-12-31	Free cash flow	-3378000	Operating Cash Flow: -1587000 Open source Capital Expenditure: 1791000 Open source
20042004-12-31	Free cash flow	46003000	Operating Cash Flow: 49487000 Open source Capital Expenditure: 3484000 Open source
20052005-12-31	Free cash flow	18099000	Operating Cash Flow: 20297000 Open source Capital Expenditure: 2198000 Open source
20062006-12-31	Free cash flow	87412000	Operating Cash Flow: 91812000 Open source Capital Expenditure: 4400000 Open source
20072007-12-31	Free cash flow	40724000	Operating Cash Flow: 63682000 Open source Capital Expenditure: 22958000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

48% 2007

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Liabilities / assets	Not reported	No source recorded
19991999-12-31	Liabilities / assets	67.4%	Total Liabilities: 7462180 Open source Total Assets: 11077744 Open source
20002000-12-31	Liabilities / assets	23%	Total Liabilities: 11511000 Open source Total Assets: 50083000 Open source
20012001-12-31	Liabilities / assets	15.7%	Total Liabilities: 26786000 Open source Total Assets: 170150000 Open source
20022002-12-31	Liabilities / assets	13.4%	Total Liabilities: 47249000 Open source Total Assets: 352932000 Open source
20032003-12-31	Liabilities / assets	6%	Total Liabilities: 19376000 Open source Total Assets: 325153000 Open source
20042004-12-31	Liabilities / assets	38.1%	Total Liabilities: 190075000 Open source Total Assets: 498484000 Open source
20052005-12-31	Liabilities / assets	35.8%	Total Liabilities: 189569000 Open source Total Assets: 529705000 Open source
20062006-12-31	Liabilities / assets	34.3%	Total Liabilities: 202182000 Open source Total Assets: 590005000 Open source
20072007-12-31	Liabilities / assets	48%	Total Liabilities: 391671000 Open source Total Assets: 816668000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

5.73× 2007

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Current assets / current liabilities	Not reported	No source recorded
19991999-12-31	Current assets / current liabilities	0.87×	Current Assets: 5023320 Open source Current Liabilities: 5757204 Open source
20002000-12-31	Current assets / current liabilities	2.37×	Current Assets: 26130000 Open source Current Liabilities: 11023000 Open source
20012001-12-31	Current assets / current liabilities	2.75×	Current Assets: 73305000 Open source Current Liabilities: 26642000 Open source
20022002-12-31	Current assets / current liabilities	1.98×	Current Assets: 90817000 Open source Current Liabilities: 45863000 Open source
20032003-12-31	Current assets / current liabilities	4.29×	Current Assets: 80901000 Open source Current Liabilities: 18871000 Open source
20042004-12-31	Current assets / current liabilities	7.22×	Current Assets: 253317000 Open source Current Liabilities: 35077000 Open source
20052005-12-31	Current assets / current liabilities	6.68×	Current Assets: 204388000 Open source Current Liabilities: 30575000 Open source
20062006-12-31	Current assets / current liabilities	7.11×	Current Assets: 269067000 Open source Current Liabilities: 37839000 Open source
20072007-12-31	Current assets / current liabilities	5.73×	Current Assets: 346648000 Open source Current Liabilities: 60521000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1998 1998-01-01 – 1998-12-31	USD 135,554 Exact value Exact value: 135554 USD 1998-01-01 – 1998-12-31: 135554 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCIELE PHARMA, INC. · 1998-12-31 SCIELE PHARMA, INC. (edgar:1106773) Net Income: 135554 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: 135554 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0000950144-01-003511.txt#2441 The citation records this snapshot. The page link may show a newer release later.	−USD 180,542 Exact value Exact value: -180542 USD 1998-01-01 – 1998-12-31: -180542 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCIELE PHARMA, INC. · 1998-12-31 SCIELE PHARMA, INC. (edgar:1106773) Operating Cash Flow: -180542 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -180542 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0000950144-01-003511.txt#2458 The citation records this snapshot. The page link may show a newer release later.	USD 208,464 Exact value Exact value: 208464 USD 1998-01-01 – 1998-12-31: 208464 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCIELE PHARMA, INC. · 1998-12-31 SCIELE PHARMA, INC. (edgar:1106773) Capital Expenditure: 208464 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 208464 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0000950144-01-003511.txt#2462 The citation records this snapshot. The page link may show a newer release later.	−USD 389,006 Calculation and evidence -180542 − 208464 USD Exact free cash flow: -389006 USD 1998-01-01 – 1998-12-31: -180542 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 208464 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCIELE PHARMA, INC. · 1998-12-31 SCIELE PHARMA, INC. (edgar:1106773) Free cash flow: -389006 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -180542 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0000950144-01-003511.txt#2458 Input fundies:CapitalExpenditure: 208464 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0000950144-01-003511.txt#2462 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	USD 770,000 Exact value Exact value: 770000 USD 1999-01-01 – 1999-12-31: 770000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCIELE PHARMA, INC. · 1999-12-31 SCIELE PHARMA, INC. (edgar:1106773) Net Income: 770000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: 770000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0000950144-02-002997.txt#2822 The citation records this snapshot. The page link may show a newer release later.	USD 1.02 million Exact value Exact value: 1019000 USD 1999-01-01 – 1999-12-31: 1019000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCIELE PHARMA, INC. · 1999-12-31 SCIELE PHARMA, INC. (edgar:1106773) Operating Cash Flow: 1019000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1019000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0000950144-02-002997.txt#2841 The citation records this snapshot. The page link may show a newer release later.	USD 186,000 Exact value Exact value: 186000 USD 1999-01-01 – 1999-12-31: 186000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCIELE PHARMA, INC. · 1999-12-31 SCIELE PHARMA, INC. (edgar:1106773) Capital Expenditure: 186000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 186000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0000950144-02-002997.txt#2844 The citation records this snapshot. The page link may show a newer release later.	USD 833,000 Calculation and evidence 1019000 − 186000 USD Exact free cash flow: 833000 USD 1999-01-01 – 1999-12-31: 1019000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 186000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCIELE PHARMA, INC. · 1999-12-31 SCIELE PHARMA, INC. (edgar:1106773) Free cash flow: 833000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1019000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0000950144-02-002997.txt#2841 Input fundies:CapitalExpenditure: 186000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0000950144-02-002997.txt#2844 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	USD 2.51 million Exact value Exact value: 2507000 USD 2000-01-01 – 2000-12-31: 2507000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCIELE PHARMA, INC. · 2000-12-31 SCIELE PHARMA, INC. (edgar:1106773) Net Income: 2507000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: 2507000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-03-009120.txt#6619 The citation records this snapshot. The page link may show a newer release later.	USD 3.28 million Exact value Exact value: 3275000 USD 2000-01-01 – 2000-12-31: 3275000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCIELE PHARMA, INC. · 2000-12-31 SCIELE PHARMA, INC. (edgar:1106773) Operating Cash Flow: 3275000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 3275000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-03-009120.txt#6889 The citation records this snapshot. The page link may show a newer release later.	USD 547,000 Exact value Exact value: 547000 USD 2000-01-01 – 2000-12-31: 547000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCIELE PHARMA, INC. · 2000-12-31 SCIELE PHARMA, INC. (edgar:1106773) Capital Expenditure: 547000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 547000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-03-009120.txt#6933 The citation records this snapshot. The page link may show a newer release later.	USD 2.73 million Calculation and evidence 3275000 − 547000 USD Exact free cash flow: 2728000 USD 2000-01-01 – 2000-12-31: 3275000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 547000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCIELE PHARMA, INC. · 2000-12-31 SCIELE PHARMA, INC. (edgar:1106773) Free cash flow: 2728000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 3275000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-03-009120.txt#6889 Input fundies:CapitalExpenditure: 547000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-03-009120.txt#6933 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	USD 10.72 million Exact value Exact value: 10723000 USD 2001-01-01 – 2001-12-31: 10723000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCIELE PHARMA, INC. · 2001-12-31 SCIELE PHARMA, INC. (edgar:1106773) Net Income: 10723000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: 10723000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-04-006151.txt#6279 The citation records this snapshot. The page link may show a newer release later.	USD 24.05 million Exact value Exact value: 24047000 USD 2001-01-01 – 2001-12-31: 24047000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCIELE PHARMA, INC. · 2001-12-31 SCIELE PHARMA, INC. (edgar:1106773) Operating Cash Flow: 24047000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 24047000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-04-006151.txt#6533 The citation records this snapshot. The page link may show a newer release later.	USD 191,000 Exact value Exact value: 191000 USD 2001-01-01 – 2001-12-31: 191000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCIELE PHARMA, INC. · 2001-12-31 SCIELE PHARMA, INC. (edgar:1106773) Capital Expenditure: 191000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 191000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-04-006151.txt#6577 The citation records this snapshot. The page link may show a newer release later.	USD 23.86 million Calculation and evidence 24047000 − 191000 USD Exact free cash flow: 23856000 USD 2001-01-01 – 2001-12-31: 24047000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 191000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCIELE PHARMA, INC. · 2001-12-31 SCIELE PHARMA, INC. (edgar:1106773) Free cash flow: 23856000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 24047000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-04-006151.txt#6533 Input fundies:CapitalExpenditure: 191000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-04-006151.txt#6577 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	USD 6.17 million Exact value Exact value: 6166000 USD 2002-01-01 – 2002-12-31: 6166000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCIELE PHARMA, INC. · 2002-12-31 SCIELE PHARMA, INC. (edgar:1106773) Net Income: 6166000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: 6166000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-05-006185.txt#6982 The citation records this snapshot. The page link may show a newer release later.	USD 27.31 million Exact value Exact value: 27313000 USD 2002-01-01 – 2002-12-31: 27313000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCIELE PHARMA, INC. · 2002-12-31 SCIELE PHARMA, INC. (edgar:1106773) Operating Cash Flow: 27313000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 27313000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-05-006185.txt#7236 The citation records this snapshot. The page link may show a newer release later.	USD 1.34 million Exact value Exact value: 1340000 USD 2002-01-01 – 2002-12-31: 1340000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCIELE PHARMA, INC. · 2002-12-31 SCIELE PHARMA, INC. (edgar:1106773) Capital Expenditure: 1340000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1340000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-05-006185.txt#7294 The citation records this snapshot. The page link may show a newer release later.	USD 25.97 million Calculation and evidence 27313000 − 1340000 USD Exact free cash flow: 25973000 USD 2002-01-01 – 2002-12-31: 27313000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 1340000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCIELE PHARMA, INC. · 2002-12-31 SCIELE PHARMA, INC. (edgar:1106773) Free cash flow: 25973000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 27313000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-05-006185.txt#7236 Input fundies:CapitalExpenditure: 1340000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-05-006185.txt#7294 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 1.74 million Exact value Exact value: -1738000 USD 2003-01-01 – 2003-12-31: -1738000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCIELE PHARMA, INC. · 2003-12-31 SCIELE PHARMA, INC. (edgar:1106773) Net Income: -1738000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -1738000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001104659-06-012316.txt#14154 The citation records this snapshot. The page link may show a newer release later.	−USD 1.59 million Exact value Exact value: -1587000 USD 2003-01-01 – 2003-12-31: -1587000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCIELE PHARMA, INC. · 2003-12-31 SCIELE PHARMA, INC. (edgar:1106773) Operating Cash Flow: -1587000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1587000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001104659-06-012316.txt#14607 The citation records this snapshot. The page link may show a newer release later.	USD 1.79 million Exact value Exact value: 1791000 USD 2003-01-01 – 2003-12-31: 1791000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCIELE PHARMA, INC. · 2003-12-31 SCIELE PHARMA, INC. (edgar:1106773) Capital Expenditure: 1791000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1791000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001104659-06-012316.txt#14712 The citation records this snapshot. The page link may show a newer release later.	−USD 3.38 million Calculation and evidence -1587000 − 1791000 USD Exact free cash flow: -3378000 USD 2003-01-01 – 2003-12-31: -1587000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 1791000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCIELE PHARMA, INC. · 2003-12-31 SCIELE PHARMA, INC. (edgar:1106773) Free cash flow: -3378000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -1587000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001104659-06-012316.txt#14607 Input fundies:CapitalExpenditure: 1791000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001104659-06-012316.txt#14712 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	USD 26.55 million Exact value Exact value: 26554000 USD 2004-01-01 – 2004-12-31: 26554000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCIELE PHARMA, INC. · 2004-12-31 SCIELE PHARMA, INC. (edgar:1106773) Net Income: 26554000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: 26554000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001104659-07-014442.txt#15007 The citation records this snapshot. The page link may show a newer release later.	USD 49.49 million Exact value Exact value: 49487000 USD 2004-01-01 – 2004-12-31: 49487000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCIELE PHARMA, INC. · 2004-12-31 SCIELE PHARMA, INC. (edgar:1106773) Operating Cash Flow: 49487000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 49487000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001104659-07-014442.txt#15446 The citation records this snapshot. The page link may show a newer release later.	USD 3.48 million Exact value Exact value: 3484000 USD 2004-01-01 – 2004-12-31: 3484000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCIELE PHARMA, INC. · 2004-12-31 SCIELE PHARMA, INC. (edgar:1106773) Capital Expenditure: 3484000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3484000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001104659-07-014442.txt#15553 The citation records this snapshot. The page link may show a newer release later.	USD 46 million Calculation and evidence 49487000 − 3484000 USD Exact free cash flow: 46003000 USD 2004-01-01 – 2004-12-31: 49487000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 3484000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCIELE PHARMA, INC. · 2004-12-31 SCIELE PHARMA, INC. (edgar:1106773) Free cash flow: 46003000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 49487000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001104659-07-014442.txt#15446 Input fundies:CapitalExpenditure: 3484000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001104659-07-014442.txt#15553 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	USD 39.21 million Exact value Exact value: 39209000 USD 2005-01-01 – 2005-12-31: 39209000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCIELE PHARMA, INC. · 2005-12-31 SCIELE PHARMA, INC. (edgar:1106773) Net Income: 39209000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 39209000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#7959 The citation records this snapshot. The page link may show a newer release later.	USD 20.3 million Exact value Exact value: 20297000 USD 2005-01-01 – 2005-12-31: 20297000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCIELE PHARMA, INC. · 2005-12-31 SCIELE PHARMA, INC. (edgar:1106773) Operating Cash Flow: 20297000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 20297000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8243 The citation records this snapshot. The page link may show a newer release later.	USD 2.2 million Exact value Exact value: 2198000 USD 2005-01-01 – 2005-12-31: 2198000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCIELE PHARMA, INC. · 2005-12-31 SCIELE PHARMA, INC. (edgar:1106773) Capital Expenditure: 2198000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2198000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8297 The citation records this snapshot. The page link may show a newer release later.	USD 18.1 million Calculation and evidence 20297000 − 2198000 USD Exact free cash flow: 18099000 USD 2005-01-01 – 2005-12-31: 20297000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 2198000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCIELE PHARMA, INC. · 2005-12-31 SCIELE PHARMA, INC. (edgar:1106773) Free cash flow: 18099000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 20297000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8243 Input fundies:CapitalExpenditure: 2198000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8297 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	USD 45.24 million Exact value Exact value: 45244000 USD 2006-01-01 – 2006-12-31: 45244000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCIELE PHARMA, INC. · 2006-12-31 SCIELE PHARMA, INC. (edgar:1106773) Net Income: 45244000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: 45244000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#7959 The citation records this snapshot. The page link may show a newer release later.	USD 91.81 million Exact value Exact value: 91812000 USD 2006-01-01 – 2006-12-31: 91812000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCIELE PHARMA, INC. · 2006-12-31 SCIELE PHARMA, INC. (edgar:1106773) Operating Cash Flow: 91812000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 91812000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8243 The citation records this snapshot. The page link may show a newer release later.	USD 4.4 million Exact value Exact value: 4400000 USD 2006-01-01 – 2006-12-31: 4400000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCIELE PHARMA, INC. · 2006-12-31 SCIELE PHARMA, INC. (edgar:1106773) Capital Expenditure: 4400000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4400000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8297 The citation records this snapshot. The page link may show a newer release later.	USD 87.41 million Calculation and evidence 91812000 − 4400000 USD Exact free cash flow: 87412000 USD 2006-01-01 – 2006-12-31: 91812000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 4400000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCIELE PHARMA, INC. · 2006-12-31 SCIELE PHARMA, INC. (edgar:1106773) Free cash flow: 87412000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 91812000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8243 Input fundies:CapitalExpenditure: 4400000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8297 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	USD 45.41 million Exact value Exact value: 45407000 USD 2007-01-01 – 2007-12-31: 45407000 USD Inspect Net Income Open source Share or cite Citation for Net Income · SCIELE PHARMA, INC. · 2007-12-31 SCIELE PHARMA, INC. (edgar:1106773) Net Income: 45407000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: 45407000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#7959 The citation records this snapshot. The page link may show a newer release later.	USD 63.68 million Exact value Exact value: 63682000 USD 2007-01-01 – 2007-12-31: 63682000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · SCIELE PHARMA, INC. · 2007-12-31 SCIELE PHARMA, INC. (edgar:1106773) Operating Cash Flow: 63682000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 63682000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8243 The citation records this snapshot. The page link may show a newer release later.	USD 22.96 million Exact value Exact value: 22958000 USD 2007-01-01 – 2007-12-31: 22958000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · SCIELE PHARMA, INC. · 2007-12-31 SCIELE PHARMA, INC. (edgar:1106773) Capital Expenditure: 22958000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 22958000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8297 The citation records this snapshot. The page link may show a newer release later.	USD 40.72 million Calculation and evidence 63682000 − 22958000 USD Exact free cash flow: 40724000 USD 2007-01-01 – 2007-12-31: 63682000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 22958000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · SCIELE PHARMA, INC. · 2007-12-31 SCIELE PHARMA, INC. (edgar:1106773) Free cash flow: 40724000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T13:33:37Z Snapshot: 48c1111775b3373cd9239e927f535c1449ff49143986043759b9962d1e0cd48a Dimensions: Consolidated View: https://fundies.io/companies/edgar/1106773?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 63682000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8243 Input fundies:CapitalExpenditure: 22958000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1106773/0001047469-08-002101.txt#8297 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

40 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001106773, 1106773, edgar:1106773

Also known as FIRST HORIZON PHARMACEUTICAL CORP

SCIELE PHARMA, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2007 2007-01-01 – 2007-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation